Candice Fitzgerald

Bio:

Candice Fitzgerald is a pharmaceutical executive with 25+ year�s experience in clinical operations and medical affairs across multi-national pharmaceutical companies (Roche, AstraZeneca, Alexion, Boehringer-Ingelheim and Novo Nordisk). She has held various positions at Vice President level, setting strategic direction and vision, implementing and leading global organisational transformative change, cross functional initiatives enhancing pipeline execution, evidence gap identification and launch readiness. Other accomplishments include delivery of new target operating models (hybrid FSP / FSO), digital transformations, and customer engagement models that significantly enhanced productivity across the clinical development value chain. Her global leadership and executive oversight experience spans early to late stage development across 50 countries with diverse cultures and complexities. Originally from Australia, she has enjoyed an international career moving to Germany with her family in 2021, and now currently located in Zurich, Switzerland. Candice holds a Masters Medical Science (Drug Development), University of NSW, Australia; a Bachelor of Applied Science (Health Information Management), University of Sydney, Australia; and a Harvard Certificate Executive Program for Senior Life Sciences.